Vibliome Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $22M

  • Investors
  • 2

Vibliome General Information

Description

Developer of small-molecule Type II kinase inhibitors designed to treat inflammatory diseases and castration-resistant prostate cancer. The company is focused on analyzing the design of Type II inhibitors that lock kinase targets in an inactive conformation, helping in identifying unique similarities and differences between kinases, enabling clinical researchers to develop drugs for cancer as well as other chronic diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 533 East Mendenhall Street
  • Bozeman, MT 59715
  • United States
+1 (406)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 533 East Mendenhall Street
  • Bozeman, MT 59715
  • United States
+1 (406)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vibliome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 24-Feb-2022 $22M Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 15-Feb-2019 Completed Product Development
2. Angel (individual) 12-Apr-2018 $113K $113K Completed Startup
1. Grant 02-Nov-2017 $500K Completed Startup
To view Vibliome’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vibliome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small-molecule Type II kinase inhibitors designed to treat inflammatory diseases and castration-resistant p
Drug Discovery
Bozeman, MT
11 As of 2023

San Diego, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vibliome Competitors (2)

One of Vibliome’s 2 competitors is Plexium, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Plexium Venture Capital-Backed San Diego, CA
AVEO Oncology Formerly VC-backed Boston, MA
You’re viewing 2 of 2 competitors. Get the full list »

Vibliome Patents

Vibliome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026228825-A1 Crystalline forms of plk4 modulating compounds Pending 30-Apr-2025
AU-2024369826-A1 Plk4 modulators Pending 30-Oct-2023
EP-4801907-A1 Plk4 modulators Pending 30-Oct-2023
WO-2025096463-A1 Plk4 modulators Inactive 30-Oct-2023
WO-2023183444-A1 Modulators of protein kinases Inactive 24-Mar-2022 C07D473/00
To view Vibliome’s complete patent history, request access »

Vibliome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vibliome Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deerfield Management Venture Capital Minority
Male Contraception Initiative (MCI) Corporation
To view Vibliome’s complete investors history, request access »

Vibliome FAQs

  • When was Vibliome founded?

    Vibliome was founded in 2017.

  • Where is Vibliome headquartered?

    Vibliome is headquartered in Bozeman, MT.

  • What is the size of Vibliome?

    Vibliome has 11 total employees.

  • What industry is Vibliome in?

    Vibliome’s primary industry is Drug Discovery.

  • Is Vibliome a private or public company?

    Vibliome is a Private company.

  • What is Vibliome’s current revenue?

    The current revenue for Vibliome is .

  • How much funding has Vibliome raised over time?

    Vibliome has raised $38.1M.

  • Who are Vibliome’s investors?

    Deerfield Management and Male Contraception Initiative (MCI) have invested in Vibliome.

  • Who are Vibliome’s competitors?

    Plexium and AVEO Oncology are competitors of Vibliome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process